Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Kröger, Nicolaus  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Daghia, G., Zabelina, T., Zeck, G., von Pein, U.-M., Christopeit, M., Wolschke, C., Ayuk, F., and Kröger, N. (2019). Allogeneic stem cell transplantation for myelofibrosis patients aged ≥ 65 years.Eur J Haematol.
Mannina, D., Gagelmann, N., Badbaran, A., Ditschkowski, M., Bogdanov, R., Robin, M., Cassinat, B., Heuser, M., Shahswar, R., Thol, F., et al. (2019). Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL-mutation.Eur J Haematol.
Bazarbachi, A.Hamid, Hamed, R.Al, Labopin, M., Afanasyev, B., Hamladji, R.-M., Beelen, D., Eder, M., Scheid, C., Wu, D., Bunjes, D., et al. (2019). Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.Bone Marrow Transplant.
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016). Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med374, 43-53.
Palmer, J., Kosiorek, H.E., Wolschke, C., Fauble, V.D.S., Butterfield, R., Geyer, H., Scherber, R.M., Dueck, A.C., Gathany, A., Mesa, R.A., et al. (2019). Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis.Biol Blood Marrow Transplant.
Triviai, I., Zeschke, S., Rentel, J., Spanakis, M., Scherer, T., Gabdoulline, R., Panagiota, V., Thol, F., Heuser, M., Stocking, C., et al. (2018). ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF.Leukemia.

Pages